ÂÜÀòÂÒÂ×

Lynn Kamen has extensive work experience in the field of scientific research and development. They currently hold the position of Scientific Officer and Executive Director at BioAgilytix since April 2022. Prior to this, Lynn worked at Genentech, where they held various roles including Principal Scientist from May 2021 to April 2022, Senior Scientist from March 2019 to May 2021, and Scientist from September 2014 to March 2019. Lynn also served as a Lead Scientist at Alector Pharmaceuticals from October 2013 to June 2014, and as a Scientist at Sutro Biopharma, Inc. from June 2013 to October 2013. They have experience as a Scientist at Portola Pharmaceuticals from January 2011 to June 2013. Lynn's professional journey began at UCSF, where they worked as a Postdoctoral Fellow from October 2007 to January 2011. They also gained experience as a Graduate Student at the University of Michigan from 2001 to 2007.

Lynn Kamen received their Ph.D. in Immunology from the University of Michigan in 2007. Prior to that, they earned a B.A. in Biology, with a minor in Math and Chemistry, from Wheaton College Massachusetts in 2001.